Literature DB >> 15990127

Positive benefits of a pharmacist-managed hypertension clinic in Nigeria.

W O Erhun1, E O Agbani, E E Bolaji.   

Abstract

OBJECTIVE: The aim of this study was to determine whether the provision of further practice-based support by pharmacists will bring about improved outcomes for blood pressure (BP) control in middle-aged and elderly Nigerian hypertensive patients managed with combination diuretics (amiloride hydrochloride 5 mg+hydrochlorothiazide 50 mg) and/or methyl dopa at the primary care level. DESIGN AND
SETTING: This was a 1-year prospective, randomized cohort study of the outpatients of a state comprehensive health centre in South-western Nigeria. Free primary health services including free drugs were provided for all patients. PATIENTS AND
METHOD: The study population comprised 51 Nigerian patients with uncomplicated hypertension aged 45 years or more, with a 0.2-3.0-year history of hypertension, registered at the Comprehensive Health Centre, Ife between October 2002 and March 2003. They were invited into the pharmacist-managed hypertension clinic and followed for the study period. Participating pharmacists counselled for current medication, personalized goals of lifestyle modification stressing weight loss and/or increased activity, increased patient awareness by providing relevant education about hypertension and associated/related diseases, adjusted drug therapy to optimize effectiveness and minimize adverse events, utilized treatment schedules that enhanced patients' adherence to therapy, and monitored treatment outcomes between enrollment and return visits. Patient satisfaction and the number of treatment failures within 6 months post enrollment were compared with retrospective data from our earlier study involving physician-managed patients under a similar setting.
RESULTS: Uncontrolled BP reduced from 92 to 36.2% by 10.15+/-5.02 days after enrollment. Treatment failures were observed at 5.9% of the total return visits (n=184) within 6 months.
CONCLUSION: Pharmacist-managed hypertension clinics can improve BP control, reduce treatment failure and increase patient satisfaction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15990127     DOI: 10.1016/j.puhe.2004.11.009

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  13 in total

Review 1.  Utilization of collaborative practice agreements between physicians and pharmacists as a mechanism to increase capacity to care for hematopoietic stem cell transplant recipients.

Authors:  Julianna A Merten; Jamie F Shapiro; Alison M Gulbis; Kamakshi V Rao; Joseph Bubalo; Scott Lanum; Ashley Morris Engemann; Sepideh Shayani; Casey Williams; Helen Leather; Tracey Walsh-Chocolaad
Journal:  Biol Blood Marrow Transplant       Date:  2013-02-15       Impact factor: 5.742

Review 2.  Phone-based intervention under nurse guidance after stroke: concept for lowering blood pressure after stroke in Sub-Saharan Africa.

Authors:  Bruce Ovbiagele
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-10-24       Impact factor: 2.136

3.  Exploring stakeholders' perceptions of a task-shifting strategy for hypertension control in Ghana: a qualitative study.

Authors:  Juliet Iwelunmor; Joyce Gyamfi; Jacob Plange-Rhule; Sarah Blackstone; Nana Kofi Quakyi; Michael Ntim; Ferdinand Zizi; Kwasi Yeboah-Awudzi; Alexis Nang-Belfubah; Gbenga Ogedegbe
Journal:  BMC Public Health       Date:  2017-02-21       Impact factor: 3.295

4.  Promotion of behavioural change in people with hypertension: an intervention study.

Authors:  Daniela Scala; Maria D'Avino; Santolo Cozzolino; Antonio Mancini; Barbara Andria; Giuseppe Caruso; Gianfranco Tajana; Domenico Caruso
Journal:  Pharm World Sci       Date:  2008-06-27

5.  Relationship between cardiovascular risk factors and high blood pressure by community pharmacists in Spain.

Authors:  Sebastián R Martínez Pérez; Pedro D Armando; Andrea C Molina Guerra; Mercé Martí Pallarés; Fernando Martínez Martínez
Journal:  Pharm World Sci       Date:  2008-12-09

6.  The impact of pharmaceutical care on patients with hypertension and their pharmacists.

Authors:  Agnieszka Skowron; Sebastian Polak; Jerzy Brandys
Journal:  Pharm Pract (Granada)       Date:  2011-06-17

Review 7.  The impact of patient support programs on adherence, clinical, humanistic, and economic patient outcomes: a targeted systematic review.

Authors:  Arijit Ganguli; Jerry Clewell; Alicia C Shillington
Journal:  Patient Prefer Adherence       Date:  2016-04-28       Impact factor: 2.711

8.  Assessing Adherence to Antihypertensive Therapy in Primary Health Care in Namibia: Findings and Implications.

Authors:  M M Nashilongo; B Singu; F Kalemeera; M Mubita; E Naikaku; A Baker; A Ferrario; B Godman; L Achieng; D Kibuule
Journal:  Cardiovasc Drugs Ther       Date:  2017-12       Impact factor: 3.727

9.  Pharmacy-based hypertension care employing mHealth in Lagos, Nigeria - a mixed methods feasibility study.

Authors:  Heleen E Nelissen; Anne L Cremers; Tochi J Okwor; Sam Kool; Frank van Leth; Lizzy Brewster; Olalekan Makinde; René Gerrets; Marleen E Hendriks; Constance Schultsz; Akin Osibogun; Anja H Van't Hoog
Journal:  BMC Health Serv Res       Date:  2018-12-04       Impact factor: 2.655

10.  Quality Improvement for Cardiovascular Disease Care in Low- and Middle-Income Countries: A Systematic Review.

Authors:  Edward S Lee; Rajesh Vedanthan; Panniyammakal Jeemon; Jemima H Kamano; Preeti Kudesia; Vikram Rajan; Michael Engelgau; Andrew E Moran
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.